Impact cytomegalovirus infection organ transplant recipients Cytomegalovirus CMV single important infectious agent recipients organ transplants two-thirds patients CMV infection months transplantation infected allografts major exogenous source CMV infection transplant recipients leukocyte-containing blood products virus Three patterns CMV infection primary infection reactivation infection superinfection Primary infection clinical impact clinical effects CMV infection infectious disease syndromes pneumonia chorioretinitis immunosuppressed state lethal opportunistic infection initiation process allograft injury Progress CMV infection anti-CMV globulin certain antiviral drugs prophylaxis combination hyperimmunoglobulin ganciclovir therapy 